Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.
- Coach for SpaceX & OpenAI destroys your limiting beliefs for 88 minutes straight
- 687. Are Prediction Markets the Best Forecasting Tool Ever — or Just Another Casino?
- He Warned AI Could Destroy Us. Now The Industry Is Listening — ft. Nick Bostrom
- The Week: China’s Upper Hand, a Troubled Bond Market, and a New Mortgage Crisis
- Most Replayed Moment: Is Renting Keeping You Poor? What’s The Actual Cost Of Home Ownership? David Bach